Cardiovascular Pharmacogenomics: Current Status and Future Directions

Overview

Journal J Hum Genet

Specialty Genetics

Date 2015 Jul 17

PMID 26178435

Citations 7

Authors

Dan M Roden

Affiliations

Soon will be listed here.

Abstract

Drugs are widely used and highly effective in the treatment of heart disease. Nevertheless, in some instances, even drugs effective in a population display lack of efficacy or adverse drug reactions in individual patients, often in an apparently unpredictable fashion. This review summarizes the genomic factors now known to influence variability in responses to widely used cardiovascular drugs such as clopidogrel, warfarin, heparin and statins. Genomic approaches being used to discover new pathways in common cardiovascular diseases and thus potential new targets for drug development are described. Finally, the way in which this new information is likely to be used in an electronic medical record environment is discussed.

Citing Articles

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies.

Parvizpour S, Beyrampour-Basmenj H, Razmara J, Farhadi F, Shamsir M Bioimpacts. 2024; 14(4):29957.

PMID: 39104623 PMC: 11298019. DOI: 10.34172/bi.2023.29957.

Computational Approaches Integrated in a Digital Ecosystem Platform for a Rare Disease.

Visibelli A, Cicaloni V, Spiga O, Santucci A Front Mol Med. 2024; 2:827340.

PMID: 39086980 PMC: 11285671. DOI: 10.3389/fmmed.2022.827340.

Associations between Selected and Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias.

Moric-Janiszewska E, Smolik S, Szydlowski L, Kapral M Medicina (Kaunas). 2023; 59(12).

PMID: 38138160 PMC: 10744405. DOI: 10.3390/medicina59122057.

Estimating the efficacy of pharmacogenomics over a lifetime.

Ye Z, Mayer J, Leary E, Kitchner T, Dart R, Brilliant M Front Med (Lausanne). 2023; 10:1006743.

PMID: 38020121 PMC: 10645151. DOI: 10.3389/fmed.2023.1006743.

Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers.

Dhingra R, Vasan R Trends Cardiovasc Med. 2016; 27(2):123-133.

PMID: 27576060 PMC: 5253084. DOI: 10.1016/j.tcm.2016.07.005.

References

Kaab S, Crawford D, Sinner M, Behr E, Kannankeril P, Wilde A . A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet. 2011; 5(1):91-9. PMC: 3288202. DOI: 10.1161/CIRCGENETICS.111.960930. View

Kurose K, Sugiyama E, Saito Y . Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet. 2011; 27(1):9-54. DOI: 10.2133/dmpk.dmpk-11-rv-111. View

Ramirez A, Shi Y, Schildcrout J, Delaney J, Xu H, Oetjens M . Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Pharmacogenomics. 2012; 13(4):407-18. PMC: 3361510. DOI: 10.2217/pgs.11.164. View

Johnson J, Roden D, Lesko L, Ashley E, Klein T, Shuldiner A . Clopidogrel: a case for indication-specific pharmacogenetics. Clin Pharmacol Ther. 2012; 91(5):774-6. PMC: 3382015. DOI: 10.1038/clpt.2012.21. View

Ellinor P, Lunetta K, Albert C, Glazer N, Ritchie M, Smith A . Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012; 44(6):670-5. PMC: 3366038. DOI: 10.1038/ng.2261. View

Lu Z, Wu C, Jiang Y, Ballou L, Clausen C, Cohen I . Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome. Sci Transl Med. 2012; 4(131):131ra50. PMC: 3494282. DOI: 10.1126/scitranslmed.3003623. View

Pulley J, Denny J, Peterson J, Bernard G, Vnencak-Jones C, Ramirez A . Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharmacol Ther. 2012; 92(1):87-95. PMC: 3581305. DOI: 10.1038/clpt.2011.371. View

Parvez B, Vaglio J, Rowan S, Muhammad R, Kucera G, Stubblefield T . Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. J Am Coll Cardiol. 2012; 60(6):539-45. PMC: 3411889. DOI: 10.1016/j.jacc.2012.01.070. View

Hu M, Mak V, Tomlinson B . Intronic variants in SLCO1B1 related to statin-induced myopathy are associated with the low-density lipoprotein cholesterol response to statins in Chinese patients with hyperlipidaemia. Pharmacogenet Genomics. 2012; 22(11):803-6. DOI: 10.1097/FPC.0b013e3283557c98. View

10.

Stocker S, Morrissey K, Yee S, Castro R, Xu L, Dahlin A . The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin. Clin Pharmacol Ther. 2012; 93(2):186-94. PMC: 3671611. DOI: 10.1038/clpt.2012.210. View

11.

Manolio T, Chisholm R, Ozenberger B, Roden D, Williams M, Wilson R . Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013; 15(4):258-67. PMC: 3835144. DOI: 10.1038/gim.2012.157. View

12.

Cho Y, Moon P, Lee J, Singh T, Kang W, Lee H . Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity. Proteomics. 2013; 13(8):1257-75. DOI: 10.1002/pmic.201200368. View

13.

Tang W, Wang Z, Levison B, Koeth R, Britt E, Fu X . Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368(17):1575-84. PMC: 3701945. DOI: 10.1056/NEJMoa1109400. View

14.

Koeth R, Wang Z, Levison B, Buffa J, Org E, Sheehy B . Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013; 19(5):576-85. PMC: 3650111. DOI: 10.1038/nm.3145. View

15.

Parvez B, Shoemaker M, Muhammad R, Richardson R, Jiang L, Blair M . Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. Heart Rhythm. 2013; 10(6):849-55. PMC: 3690553. DOI: 10.1016/j.hrthm.2013.02.018. View

16.

Perera M, Cavallari L, Limdi N, Gamazon E, Konkashbaev A, Daneshjou R . Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet. 2013; 382(9894):790-6. PMC: 3759580. DOI: 10.1016/S0140-6736(13)60681-9. View

17.

Mangravite L, Engelhardt B, Medina M, Smith J, Brown C, Chasman D . A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature. 2013; 502(7471):377-80. PMC: 3933266. DOI: 10.1038/nature12508. View

18.

Behr E, Ritchie M, Tanaka T, Kaab S, Crawford D, Nicoletti P . Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes. PLoS One. 2013; 8(11):e78511. PMC: 3819377. DOI: 10.1371/journal.pone.0078511. View

19.

Lu Z, Jiang Y, Wu C, Ballou L, Liu S, Carpenter E . Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart. Diabetes. 2013; 62(12):4257-65. PMC: 3837031. DOI: 10.2337/db13-0420. View

20.

Verhoef T, Ragia G, de Boer A, Barallon R, Kolovou G, Kolovou V . A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med. 2013; 369(24):2304-12. DOI: 10.1056/NEJMoa1311388. View